The Abortion Pill Legal Standoff Endangers Access to All Drugs
WiredThe abortion pill mifepristone will remain available in the US for now—but its long-term fate is uncertain as a bitter legal battle unfolds. A federal appeals court ruled yesterday in favor of keeping the drug on the market but rolled back changes the US Food and Drug Administration has made in recent years to expand access to it. The order, issued by the US Fifth Circuit Court of Appeals, partly overruled last week’s decision by Judge Matthew Kacsmaryk of the Northern District of Texas invalidating the FDA’s approval of the pill in 2000. The appeals court said too much time had passed since the drug’s approval to bring a lawsuit against the FDA for authorizing mifepristone. “Even though this softens the blow of Judge Kacsmaryk’s ruling, it is just as problematic and concerning,” says David Cohen, a professor of law at Drexel University, referring to the restrictions that the appeals court placed on the pill.